Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin

Hepato-Gastroenterology

Volumn 59, Issue 113, 2012, Pages 62-66

  Arai, Makoto ^a   Matsumura, Tomoaki ^a   Tsuchiya, Naoko ^b   Sadakane, Chiharu ^b   Inami, Ryouhei ^b   Suzuki, Takuto ^a   Yoshikawa, Masaharu ^a   Imazeki, Fumio ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TSUMURA AND CO   (Japan)

Author keywords

Functional dyspepsia; Ghrelin; Human; Rikkunshito

Indexed keywords

DOMPERIDONE; GHRELIN; HERBACEOUS AGENT; RIKKUNSHITO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DYSPEPSIA; FEMALE; GASTROINTESTINAL REFLUX; HORMONE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; TRADITIONAL MEDICINE; TREATMENT OUTCOME;

ACYLATION; ADULT; AGED; BODY WEIGHT; DOMPERIDONE; DRUGS, CHINESE HERBAL; DYSPEPSIA; FEMALE; GASTROINTESTINAL AGENTS; GHRELIN; HUMANS; JAPAN; MALE; MIDDLE AGED; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84863230209     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11246     Document Type: Article

References (32)

1. Mearin F, De Ribot X, Balboa A, et al.: Duodenogastric bile reflux and gastrointestinal motility in pathogenesis of functional dyspepsia. Role of cholecystectomy. Dig Dis Sci 1995; 40:1703-1709.
2. Peura DA, Kovacs TO, Metz DC, et al.: Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med 2004; 116:740-748. (Pubitemid 38622310)
3. Hiyama T, Yoshihara M, Matsuo K, et al.: Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2007; 22:1566-1570. (Pubitemid 47383326)
4. Hiyama T, Yoshihara M, Matsuo K, et al.: Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. J Gastroenterol Hepatol 2007; 22:304-310. (Pubitemid 46238756)
5. Gwee KA, Teng L, Wong RK, et al.: The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2009; 21:417-424.
6. Chen SL, Ji JR, Xu P, et al.: Effect of domperidone therapy on nocturnal dyspeptic symptoms of functional dyspepsia patients. World J Gastroenterol 2010; 16:613-617.
7. Popovic V, Duntas LH: Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity. Nutr Neurosci 2005; 8:1-5. (Pubitemid 40637242)
8. Kojima M, Hosoda H, Date Y, et al.: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656-660. (Pubitemid 129516334)
9. Wolf I, Sadetzki S, Kanety H, et al.: Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 2006; 106:966-973. (Pubitemid 43238466)
10. Ataseven H, Bahcecioglu IH, Kuzu N, Y et al.: The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm 2006; 2006:78380.
11. Shinomiya T, Fukunaga M, Akamizu T, et al.: Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol 2005; 40:648-653. (Pubitemid 40827526)
12. Garcia JM, Garcia-Touza M, Hijazi RA, et al.: Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 2005; 90:2920-2926. (Pubitemid 40686344)
13. Takamori K, Mizuta Y, Takeshima F, et al.: Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia. J Clin Gastroenterol 2007; 41:477-483. (Pubitemid 46642535)
14. Perboni S, Inui A: Appetite and gastrointestinal motility: role of ghrelin-family peptides. Clin Nutr 2010; 29:227-234.
15. Shindo T, Futagami S, Hiratsuka T, et al.: Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion 2009; 79:65-72.
16. Matsumura T, Arai M, Yonemitsu Y, et al.: The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol 2009; 45:300-307.
17. Tack J, Talley NJ, Camilleri M, et al.: Functional gastroduodenal disorders. Gastroenterology 2006; 130:1466-1479.
18. Revicki DA, Wood M, Wiklund I, Crawley J: Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7:75-83. (Pubitemid 28113967)
19. Zung WW, Richards CB, Short MJ: Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965; 13:508-515.
20. Baldelli R, Bellone S, Castellino N, et al.: Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children. Clin Endocrinol (Oxf) 2006; 64:255-259.
21. Gibson W, Liu J, Gaylinn B, et al.: Effects of glucose and insulin on acyl ghrelin and desacyl ghrelin, leptin, and adiponectin in pregnant women with diabetes. Metabolism 2010; 59:841-847.
22. Wang Y, Nishi M, Doi A, et al.: Ghrelin inhibits insulin secretion through the AMPK-UCP2 pathway in beta cells. FEBS Lett 2010; 584:1503-1508.
23. Tomono H, Ito Y, Watanabe T: [Successful antiemetic treatment of TSUMURA Rikkunshi-to Extract Granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient]. Gan To Kagaku Ryoho 2006; 33:1129-1131.
24. Tatsuta M, Iishi H: Effect of treatment with liu-Jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1993; 7:459-462. (Pubitemid 23267023)
25. Kido T, Nakai Y, Kase Y, et al.: Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine. J Pharmacol Sci 2005; 98:161-167. (Pubitemid 40943722)
26. Hayakawa T, Arakawa T, Kase Y, et al.: Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res 1999; 25:211-218. (Pubitemid 29497741)
27. Oka T, Tamagawa Y, Hayashida S, et al.: Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine. Biopsychosoc Med 2007; 1:21.
28. Takeda H, Sadakane C, Hattori T, et al.: Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008; 134:2004-2013. (Pubitemid 351783256)
29. Takeda H, Muto S, Hattori T, et al.: Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition. Endocrinology 2010; 151:244-252.
30. Yakabi K, Kurosawa S, Tamai M, et al.: Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction. Regui Pept 2010; 161:97-105.
31. Akamizu T, Iwakura H, Ariyasu H, et al.; FD Clinical Study Team: Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol 2008; 158:491-498. (Pubitemid 351606344)
32. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ: The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004; 127:1329-1337. (Pubitemid 39457759)